---
category: news
title: "NASDAQ Company Advances AI-Enhanced Protein Design Technology for Cellular Therapy Development: Avalon Globocare, Inc. (NASDAQ: AVCO)"
excerpt: "Avalon GloboCare Corp. (NASDAQ:AVCO), a clinical-stage global developer of cell-based technologies and therapeutics, today"
publishedDateTime: 2021-12-10T17:35:00Z
originalUrl: "https://www.benzinga.com/pressreleases/21/12/ab24550761/nasdaq-company-advances-ai-enhanced-protein-design-technology-for-cellular-therapy-development-av"
webUrl: "https://www.benzinga.com/pressreleases/21/12/ab24550761/nasdaq-company-advances-ai-enhanced-protein-design-technology-for-cellular-therapy-development-av"
ampWebUrl: "https://www.benzinga.com/amp/content/24550761"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/24550761"
type: article
quality: 23
heat: 23
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI
  - Google AI

secured: "l8P1Nmwxedb+mR+q7MIofuQn7kGfXleAbghNMoEC8DBj6A1aX2VhntzBz1yMIxvcqOtou91iV1lGfCMpqeiJHlCzoXseC/oQ8UwbuKFYV36C3gUwWRElQndgx85HUV/Gp+QU3UbYXfqK5ZUuRJ8iDLdquJLP55Fy8vaPEdTqUhLaRWrzelZIkstOI3H+iUpPezAVOLbvCPBTHRypMVlXeffwdpDZBPiXdxnwjkObEE2uV7jjeXRLUU0jI/UzWoB3DOWg2tQ4vg1mbgoF+MoWJALOTkjxkfOAIDefEXP/Stddg7nKy8oopnHfFZHTpHygSigYDoPJ43KdDh/JwSuueuEXFv5W2l1DX5OvQMWOeH8=;QcAkZxe6ZTsE3NkEDIso5g=="
---

